Long-Term Recovery and Life After Healing
At a Glance
After pyoderma gangrenosum heals, thin, net-like scars may remain, but the disease can return at scars or injured skin. Elective procedures require stable disease and a joint plan from a dermatologist and surgeon, plus ongoing monitoring and support.
Healing from Pyoderma Gangrenosum (PG) is a major milestone, but it is rarely the end of the journey. Because the inflammation involved in PG is so destructive, it often leaves behind a permanent “fingerprint” on the skin. Understanding what to expect during long-term recovery—including the unique way your skin heals and how to safely navigate future medical procedures—is essential for protecting your health [1][2].
The Unique “Cribriform” Scar
As a PG ulcer heals, it typically leaves behind a very specific type of mark known as a cribriform scar [1]. This is often described as having a “wrinkled-paper” or “cigarette-paper” appearance [3]. Unlike the thick, raised scars (keloids) seen in other conditions, a PG scar is usually thin, slightly sunken, and may have a patterned or “net-like” texture [4].
While these scars are a sign of successful healing, they can sometimes remain tender or feel fragile [5]. It is important to know that PG can recur at scars or other traumatized sites, and a scar’s appearance does not reliably distinguish protection from recurrence. The “memory” of the disease remains in your immune system [6].
Rules for Future Surgeries and Revisions
If you are unhappy with the appearance of your scars or if you need an unrelated surgery (such as a joint replacement), you must proceed with extreme caution. Because of pathergy—the risk of new ulcers forming from trauma—any surgery can potentially trigger the disease [1][7].
- Careful Timing: Elective or reconstructive surgery is generally avoided during active disease, and should be considered only when your PG has been inactive (quiescent) for a significant period [7]. Operating while the disease is active increases the risk of a severe recurrence [7].
- A “Team” Approach: Your surgeon must work directly with your dermatologist to create a perioperative plan [8][9]. Necessary surgery should not be delayed solely because of PG, but the plan must be made jointly by the surgeon and PG specialist.
- Scar Treatments: When it comes to improving the appearance of scars, non-invasive options are often considered. Some studies have shown that laser treatments (specifically pulsed-dye or fractional lasers) can improve the texture and redness of PG scars [5]. However, laser treatment is itself a form of tissue trauma that may provoke pathergy; scar treatments are optional, specialist-dependent, and not risk-free.
Long-Term Monitoring and “Recurrence Anxiety”
Even when your skin looks clear, you remain under the care of a medical team. Monitoring is focused on two main areas:
- Infection Risk: If you are taking long-term medications to suppress your immune system, you are at a higher risk for infections [10]. Because sterile PG commonly has purulent-appearing drainage and inflammatory redness, do not diagnose infection from appearance alone. Contact your care team promptly for rapid change, systemic illness, foul odor, new necrosis, or other clinician-defined concerns [11].
- Screening for Associated Diseases: Since PG is sometimes associated with internal conditions like IBD or blood disorders, your doctor may continue to screen you for these; follow-up is individualized and guided by symptoms, though some experts suggest careful monitoring especially if you were under age 50 at diagnosis [12][13]. Any new bowel, joint, fatigue, or bruising symptoms warrant assessment at any age.
Living with the knowledge that PG could return can be emotionally draining. Recurrence rates vary widely, with some studies showing about 17% and others up to 46% of patients experiencing a flare-up later in life [14][2]. It is normal to feel “recurrence anxiety”—a sense of dread every time you notice a small scratch or bump. Keeping a photo log of your skin can help you provide clear evidence to your doctor and may offer some peace of mind by allowing you to objectively track changes [15].
You may also want to prepare a written medical-alert note for future clinicians, including the dermatologist’s perioperative contact information and your pathergy risk. If the emotional weight of the disease becomes overwhelming, do not hesitate to ask for a referral to a counselor who specializes in chronic illness. Managing the stress of PG is just as important as managing the physical wounds [16].
Common questions in this guide
What will a healed pyoderma gangrenosum scar look and feel like?
Can pyoderma gangrenosum come back in a healed scar?
When can I have elective surgery after PG?
How can doctors make surgery safer if I have a history of PG?
Are laser treatments safe for pyoderma gangrenosum scars?
How will I be monitored after PG heals?
How likely is pyoderma gangrenosum to recur?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.How can we differentiate between a normal 'wrinkled' scar and a potential early recurrence?
- 2.Given my history of PG, what extra precautions will we take if I need unavoidable surgery in the future?
- 3.Since I am on long-term immunosuppressants, what is our schedule for blood work and infection screenings?
- 4.Are there optional, non-surgical options like laser treatments that could improve my scars, and what are the risks?
- 5.How long should my disease be stable before we even consider scar revision or elective procedures?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (16)
- 1
Diagnostic Criteria of Ulcerative Pyoderma Gangrenosum: A Delphi Consensus of International Experts.
Maverakis E, Ma C, Shinkai K, et al.
JAMA dermatology 2018; (154(4)):461-466 doi:10.1001/jamadermatol.2017.5980.
PMID: 29450466 - 2
The Clinical Characteristics of Patients With Pyoderma Gangrenosum in a Tertiary Referral Hospital: A Retrospective Cohort Study.
Afacan Yıldırım E, Can Edek Y, Adısen E
The international journal of lower extremity wounds 2026; (25(1)):150-154 doi:10.1177/15347346231196957.
PMID: 37700613 - 3
Pyoderma gangrenosum with thymoma and myasthenia gravis: A case report.
Tunçez Akyürek F, Akyurek M, Zekey E, et al.
Journal of cosmetic dermatology 2021; (20(3)):943-946 doi:10.1111/jocd.13717.
PMID: 32920928 - 4
A Verrucous Plaque Healing with Cribriform Scarring.
Meena A, Mehta H, Chaterjee D, De D
Indian dermatology online journal 2024; (15(4)):640-642 doi:10.4103/idoj.idoj_380_23.
PMID: 39050081 - 5
Laser Therapy in the Treatment of Scarring Secondary to Pyoderma Gangrenosum: A Case Series.
Vague M, Shea M, Kumar I, et al.
Lasers in surgery and medicine 2026; (58(5)):373-380 doi:10.1002/lsm.70122.
PMID: 41845874 - 6
Classic Ulcerative Pyoderma Gangrenosum Is a T Cell-Mediated Disease Targeting Follicular Adnexal Structures: A Hypothesis Based on Molecular and Clinicopathologic Studies.
Wang EA, Steel A, Luxardi G, et al.
Frontiers in immunology 2017; (8()):1980 doi:10.3389/fimmu.2017.01980.
PMID: 29379508 - 7
Risk of developing pyoderma gangrenosum after procedures in patients with a known history of pyoderma gangrenosum-A retrospective analysis.
Xia FD, Liu K, Lockwood S, et al.
Journal of the American Academy of Dermatology 2018; (78(2)):310-314.e1 doi:10.1016/j.jaad.2017.09.040.
PMID: 28947285 - 8
Efficacy and safety of skin grafting in treatment of vasculitic ulcer and pyoderma gangrenosum-A systematic review.
Morgenstjerne-Schwenck LET, Knudsen JT, Prasad SC
Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society 2021; (29(2)):240-253 doi:10.1111/wrr.12882.
PMID: 33377584 - 9
Treatment Strategy for Pyoderma Gangrenosum: Skin Grafting with Immunosuppressive Drugs.
Nishimura M, Mizutani K, Yokota N, et al.
Journal of clinical medicine 2022; (11(23)) doi:10.3390/jcm11236924.
PMID: 36498498 - 10
Probable pyoderma gangrenosum complicated with cutaneous Aspergillus flavus infection: case report.
Sun S, Zhu M, Wen C
Frontiers in medicine 2026; (13()):1806433 doi:10.3389/fmed.2026.1806433.
PMID: 42100284 - 11
A case of sporotrichosis infection mimicking pyoderma gangrenosum and the role of tissue culture in diagnosis: A case report.
Tai F, Jakubovic H, Alabdulrazzaq S, Alavi A
SAGE open medical case reports 2020; (8()):2050313X20919600 doi:10.1177/2050313X20919600.
PMID: 32523696 - 12
Underlying Systemic Diseases in Pyoderma Gangrenosum: A Systematic Review and Meta-Analysis.
Kridin K, Cohen AD, Amber KT
American journal of clinical dermatology 2018; (19(4)):479-487 doi:10.1007/s40257-018-0356-7.
PMID: 29721816 - 13
The Association of Age With Clinical Presentation and Comorbidities of Pyoderma Gangrenosum.
Ashchyan HJ, Butler DC, Nelson CA, et al.
JAMA dermatology 2018; (154(4)):409-413 doi:10.1001/jamadermatol.2017.5978.
PMID: 29450453 - 14
Clinicopathological features and prognosis of pyoderma gangrenosum in Korea: A single centre, retrospective, observational study over 20 years.
Kim YJ, Lee KH, Won CH, et al.
Indian journal of dermatology, venereology and leprology 2023; (89(1)):25-34.
PMID: 35389018 - 15
Pyoderma gangrenosum: a case report highlighting the importance of early diagnosis and treatment.
Hayek SJ, Brodell RT, Doolittle JS, Jackson JD
International journal of surgery case reports 2026; (138(3)):357-362 doi:10.1097/RC9.0000000000000100.
PMID: 41847105 - 16
Post-surgical Pyoderma Gangrenosum Following Elective Aesthetic Procedures: A Case Series of 10 Patients and a Multidisciplinary Treatment Approach.
Birck MS, Padilha DZ, Borges VPB, et al.
Indian journal of plastic surgery : official publication of the Association of Plastic Surgeons of India 2026; (59(3)):218-223 doi:10.1055/s-0045-1814165.
PMID: 42592637
This page provides educational information about long-term recovery after pyoderma gangrenosum and does not constitute medical advice. Your dermatologist and surgeon should guide decisions about recurrence, infections, scars, medications, and future procedures.
Get notified when new evidence is published on Pyoderma gangrenosum.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.